For KIFC1 inhibitors, we found that both primary leukemia samples showed a higher sensitivity to AZ82 (3.5 μM, 3.9 μM) in comparison to Griseofulvin (20.2 μM, 54.4 μM) and CW069 (363.7 μM, 261.5 μM) (Fig. 6A). Here, KIFC1 is linked to leukemia.